A problem for biopharmaceutical companies comes as degraded proteins lead to ineffective and possibly dangerous medicines for their clients. Drug companies work on formulation development to protect ...
Nearly half of all drug shortages in 2022 were caused by quality issues or manufacturing delays, according to the Center for Drug Evaluation and Research (CDER). Evaluating the critical quality ...
Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
Desire to Improve Therapeutic Proteins at Molecular Level Drives Bioformulation Advances While pharmaceutical formulations have always been part science, part art, the complexity of todays drugs has ...
Stability is one of the main quality characteristics in formulation studies of prospective therapeutic biomolecules. Researchers depend on high-throughput screening techniques to reduce the funds, ...
In the world of drug discovery and clinical trials, drug formulation can make or break a product’s success, yet its role often goes underappreciated, says Christine Allen, cofounder and CEO of ...
insights from industryYoann LefeuvreDirector of Product ManagementMicrotrac In this interview, AZoNano speaks with Yoann Lefeuvre, Director of Product Management at Microtrac. Yoann discusses ...
98% of drugs do not reach the brain, as the blood–brain barrier (BBB) separates peripheral blood circulation from the central nervous system (CNS). Galmed has developed, in collaboration with Barcode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results